Your session is about to expire
← Back to Search
Cashew or Shrimp Oral Immunotherapy for Food Allergy (MOTIF Trial)
MOTIF Trial Summary
This trial is testing if cashew or shrimp OIT can help people with allergies to either cashew or shrimp. 72 participants will be treated and the trial will use DBPCFC, allergy history, clinical symptoms, and food-allergen specific IgE levels to determine if the treatment is working.
- Food Allergy
- Shrimp Allergy
- Cashew Nut Allergy
MOTIF Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowMOTIF Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.MOTIF Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is the eligibility for this trial limited to adults only?
"Patients aged between 7 and 55 years old are eligible to partake in this trial."
Do I fulfill the qualifications to partake in this research?
"The eligibility requirements for this study necessitates that applicants be allergic to shrimp and between the ages of 7 and 55. There are currently 52 positions open to participants."
Has the Food and Drug Administration given authorization to Cashew or Shrimp Oral Immunotherapy?
"Our staff has assigned Cashew or Shrimp Oral Immunotherapy a rating of 2 out of 3 due to its current status as a Phase 2 trial. This suggests that there is some evidence for safety, but no proof yet demonstrating efficacy."
Are patients still eligible to participate in this experiment?
"According to clinicaltrials.gov, this particular trial has concluded its recruitment process for the time being and was last updated in May 2021. Nevertheless, there are still 261 other medical studies actively seeking participants at present."
Share this study with friends
Copy Link
Messenger